跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,464 条关于
“ABO Holdings”
全部
3,464
临床试验
1,494
药物
623
机构
417
资讯
930
去年
GC Biopharma Expands U.S. Plasma Collection Network with FDA Approval of Calexico Facility
去年
Repare Therapeutics' Gynecological Cancer Trial Shows Mixed Results, Beigene Inks $1.5B Deal for MAT2A Inhibitor
2年前
FDA Clears IND for Arbor Biotechnologies' ABO-101 Gene-Editing Therapy for Primary Hyperoxaluria Type 1
2个月前
ABO-101 Gene Editing Therapy for Primary Hyperoxaluria Type 1 Granted Orphan Drug Designation by European Commission
11个月前
Abeona Therapeutics' ABO-503 Gene Therapy Selected for FDA's Rare Disease Endpoint Advancement Pilot Program
去年
Arbor Biotechnologies' ABO-101 Receives FDA Clearance for Phase 1/2 Trial in Primary Hyperoxaluria Type 1
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
4年前
Ultragenyx Acquires Global Rights to Abeona's Gene Therapy for Sanfilippo Syndrome Type A
第 1 页,共 93 页
上一页
下一页